Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 11019
  • 11020
  • 11021
  • …
  • ›
  • »

2025-03-04

Vela Technologies raises funds and plans reboot as Caledonian Holdings PLC

2025-03-04

IN BRIEF: Synectics lifts dividend by 50% as profit and sales climb

2025-03-04

Canadian Critical Minerals Inc.: Canadian Critical Minerals Announces Increases of Indicated Metal of 11% for Copper and 17% for Gold at the Bull River Mine

2025-03-04

IN BRIEF: PCI-PAL highlights record new business sales as loss narrows

2025-03-04

IN BRIEF: Aquis Exchange raises provisions for two tech clients

2025-03-04

Daxor Corporation Reports Increase in NAV to $7.25 Per Share and 116.5 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2024

2025-03-04

Air Transport Services Q4 Earnings Surpass Estimates, Increase Y/Y

2025-03-04

Zoomcar files to sell 133.65M shares of common stock for holders

2025-03-04

Nevro GAAP EPS of -$1.41 misses by $0.64, revenue of $105.54M beats by $2.93M

2025-03-04

Stem, Inc. Full Year Loss Widens

2025-03-04

Enlivex Therapeutics Announces Investor Webinar to Discuss Positive Interim Data from Phase I/II Allocetra™ Trial in Knee Osteoarthritis

2025-03-04

Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results

  • «
  • ‹
  • …
  • 11019
  • 11020
  • 11021
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies